CRVS Corvus Pharmaceuticals Inc

USD 1.92 0.00 0
Icon

Corvus Pharmaceuticals Inc (CRVS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.92

0.00 (0.00)%

USD 0.07B

0.38M

USD 5.25(+173.44%)

N/A

Icon

CRVS

Corvus Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 1.92
0.00 0
Take a Tour

Corvus Pharmaceuticals Inc (CRVS) Stock Forecast

Show ratings and price targets of :
USD 5.25
(+173.44%)

Based on the Corvus Pharmaceuticals Inc stock forecast from 2 analysts, the average analyst target price for Corvus Pharmaceuticals Inc is USD 5.25 over the next 12 months. Corvus Pharmaceuticals Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Corvus Pharmaceuticals Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Corvus Pharmaceuticals Inc’s stock price was USD 1.92. Corvus Pharmaceuticals Inc’s stock price has changed by +32.41% over the past week, +9.71% over the past month and +60.00% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...